3 ms·
Probably be cheaper in the long run for the U.S. government to pay all $90B (according to your figure) for all drug research, end drug patents, and non-exclusiv
by jimbokun 12y ago
Probably be cheaper in the long run for the U.S. government to pay all $90B (according to your figure) for all drug research, end drug patents, and non-exclusively license the resulting drug research at a nominal fee to manufacturers.